14 / 28
Sep 14, 2015
Mar 14, 2016
Jul 4, 2016
Jul 12, 2017
ITT (N = 119)
Responders, n (ORR, %)
23 (19%)
28 (24%)
27 (23%)
28 (24%)
Ongoing responses, n (%)
c
22 (96%)
21 (75%)
19 (70%)
19 (68%)
IC2/3
a
(n = 32)
Responders, n (ORR, %)
7 (22%)
9 (28%)
9 (28%)
9 (28%)
Ongoing responses, n (%)
c
7 (100%)
6 (67%)
6 (67%)
6 (67%)
IC0/1
b
(n = 87)
Responders, n (ORR, %)
16 (18%)
19 (22%)
18 (21%)
19 (22%)
Ongoing responses, n (%)
c
15 (94%)
15 (79%)
13 (72%)
13 (68%)
14
a
IC2/3, ≥ 5%.
b
IC0/1, < 5%.
c
Refers to responders with no subsequent progressive disease or death. Response per IRF.
Objective and Ongoing Responses Over Time
Presentado por I Durán et al. GCBC 2018.